Cough/Cold, Analgesic Patch Sales Ease Pain Of Private Label Growth In OTCs
This article was originally published in The Pink Sheet
Executive Summary
Topical analgesic sales grew double digits in 2017 on innovation and adhesive patch launches, helping drive 2.1% growth of US manufacturers' OTC drug sales in 2017 to $21.2bn, Kline & Co. independent consultant Laura Mahecha says. But private label continues to outpace branded product sales growth.